Wuhan General Group (China), Inc. (WUHN)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Oct 29, 2025
WUHN Market Cap
WUHN has a market cap or net worth of $11.03 thousand as of November 14, 2025. Its market cap has decreased by -99.93% in one year.
Market Cap
11.03K
Enterprise Value
n/a
Revenue
80.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 8, 2007, WUHN's market cap has decreased from 88.71M to 11.03K, a decrease of -99.99%. That is a compound annual growth rate of -38.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 11.03K | -99.33% |
| Dec 30, 2022 | 1.65M | -95.01% |
| Dec 31, 2021 | 33.13M | 54.95% |
| Dec 31, 2020 | 21.38M | 1,167.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 836.20M |
| Elite Pharmaceuticals | 716.54M |
| Glass House Brands | 604.34M |
| American Oncology Network | 372.31M |
| Northwest Biotherapeutics | 367.30M |
| Silence Therapeutics | 317.41M |
| Nika Pharmaceuticals | 311.89M |
| CytoDyn | 304.26M |